CO4970832A1 - Nuevas formulaciones y procesos para su fabricacion - Google Patents
Nuevas formulaciones y procesos para su fabricacionInfo
- Publication number
- CO4970832A1 CO4970832A1 CO98068459A CO98068459A CO4970832A1 CO 4970832 A1 CO4970832 A1 CO 4970832A1 CO 98068459 A CO98068459 A CO 98068459A CO 98068459 A CO98068459 A CO 98068459A CO 4970832 A1 CO4970832 A1 CO 4970832A1
- Authority
- CO
- Colombia
- Prior art keywords
- manufacture
- processes
- paroxetine
- new formulations
- solution
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Una cápsula oral tragable, que contiene paroxetina disuelta en un vehículo. Una cápsula oral tragable, que comprende una cubierta de cápsula que contiene paroxetina como la base libre o una sal o solvato farmacéuticamente aceptable de la misma, en disolución en un vehículo líquido o sólido. 1Una formulación farmacéutica, que comprende una disolución de paroxetina en una mezcla de un agente solubilizante y un lípido y/o aceite.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9724544.3A GB9724544D0 (en) | 1997-11-21 | 1997-11-21 | Novel Formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4970832A1 true CO4970832A1 (es) | 2000-11-07 |
Family
ID=10822374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO98068459A CO4970832A1 (es) | 1997-11-21 | 1998-11-20 | Nuevas formulaciones y procesos para su fabricacion |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1033986A1 (es) |
| JP (1) | JP2001523718A (es) |
| KR (1) | KR20010032320A (es) |
| CN (1) | CN1279608A (es) |
| AP (1) | AP2000001821A0 (es) |
| AR (1) | AR015485A1 (es) |
| AU (1) | AU1168099A (es) |
| BG (1) | BG104527A (es) |
| BR (1) | BR9814220A (es) |
| CO (1) | CO4970832A1 (es) |
| DZ (1) | DZ2658A1 (es) |
| EA (1) | EA200000552A1 (es) |
| GB (1) | GB9724544D0 (es) |
| HU (1) | HUP0100580A3 (es) |
| IL (1) | IL136106A0 (es) |
| MA (1) | MA24704A1 (es) |
| NO (1) | NO20002590L (es) |
| OA (1) | OA11385A (es) |
| PE (1) | PE20000381A1 (es) |
| PL (1) | PL340555A1 (es) |
| SK (1) | SK7342000A3 (es) |
| TR (1) | TR200001423T2 (es) |
| WO (1) | WO1999026625A1 (es) |
| ZA (1) | ZA9810637B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9810180D0 (en) * | 1998-05-13 | 1998-07-08 | Smithkline Beecham Plc | Novel formulation |
| EP1161241B1 (de) * | 1999-03-12 | 2005-12-07 | Aesica Pharmaceuticals Ltd. | Stabile pharmazeutische anwendungsform für paroxetin-anhydrat |
| WO2001002393A1 (en) | 1999-07-01 | 2001-01-11 | Italfarmaco S.P.A. | Complexes of paroxetine, with cyclodextrins or cyclodextrin derivatives |
| DE19930454A1 (de) * | 1999-07-02 | 2001-01-04 | Knoll Ag | Feste Paroxetin enthaltende Zubereitungen |
| US6720003B2 (en) | 2001-02-16 | 2004-04-13 | Andrx Corporation | Serotonin reuptake inhibitor formulations |
| JP2005531495A (ja) * | 2001-12-21 | 2005-10-20 | シャイア ラボラトリーズ，インコーポレイテッド | 高い物理的安定性を有する経口カプセル製剤 |
| SE0200475D0 (sv) * | 2002-02-15 | 2002-02-15 | Ltp Lipid Technologies Provide | Oral farmaceutisk beredning |
| WO2006119779A2 (en) * | 2005-05-10 | 2006-11-16 | Lifecycle Pharma A/S | A pharmaceutical composition comprising an aldosterone antagonist in form of solid solution |
| CN102740841A (zh) * | 2009-12-08 | 2012-10-17 | 株式会社一和 | 含有20-O-β-D-吡喃葡糖基-20(S)-原人参二醇的固体分散体 |
| GB201020032D0 (en) * | 2010-11-25 | 2011-01-12 | Sigmoid Pharma Ltd | Composition |
| CN103961333B (zh) * | 2014-05-07 | 2020-02-21 | 浙江华海药业股份有限公司 | 甲磺酸帕罗西汀胶囊及其制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3768536B2 (ja) * | 1995-04-03 | 2006-04-19 | アボツト・ラボラトリーズ | 低温溶融性薬物と制御放出のための添加物との均質混合物 |
| CN1249686A (zh) * | 1997-01-15 | 2000-04-05 | 史密丝克莱恩比彻姆有限公司 | 帕罗西丁制剂 |
-
1997
- 1997-11-21 GB GBGB9724544.3A patent/GB9724544D0/en not_active Ceased
-
1998
- 1998-11-18 BR BR9814220-8A patent/BR9814220A/pt not_active Application Discontinuation
- 1998-11-18 JP JP2000521827A patent/JP2001523718A/ja active Pending
- 1998-11-18 PE PE1998001126A patent/PE20000381A1/es not_active Application Discontinuation
- 1998-11-18 IL IL13610698A patent/IL136106A0/xx unknown
- 1998-11-18 EP EP98954631A patent/EP1033986A1/en not_active Withdrawn
- 1998-11-18 SK SK734-2000A patent/SK7342000A3/sk unknown
- 1998-11-18 AP APAP/P/2000/001821A patent/AP2000001821A0/en unknown
- 1998-11-18 TR TR2000/01423T patent/TR200001423T2/xx unknown
- 1998-11-18 WO PCT/GB1998/003471 patent/WO1999026625A1/en not_active Application Discontinuation
- 1998-11-18 HU HU0100580A patent/HUP0100580A3/hu unknown
- 1998-11-18 KR KR1020007005532A patent/KR20010032320A/ko not_active Application Discontinuation
- 1998-11-18 DZ DZ980268A patent/DZ2658A1/xx active
- 1998-11-18 AU AU11680/99A patent/AU1168099A/en not_active Abandoned
- 1998-11-18 PL PL98340555A patent/PL340555A1/xx unknown
- 1998-11-18 CN CN98811404A patent/CN1279608A/zh active Pending
- 1998-11-18 EA EA200000552A patent/EA200000552A1/ru unknown
- 1998-11-19 AR ARP980105880A patent/AR015485A1/es unknown
- 1998-11-19 MA MA25357A patent/MA24704A1/fr unknown
- 1998-11-20 CO CO98068459A patent/CO4970832A1/es unknown
- 1998-11-20 ZA ZA9810637A patent/ZA9810637B/xx unknown
-
2000
- 2000-05-19 NO NO20002590A patent/NO20002590L/no not_active Application Discontinuation
- 2000-05-19 OA OA1200000153A patent/OA11385A/en unknown
- 2000-06-13 BG BG104527A patent/BG104527A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL136106A0 (en) | 2001-05-20 |
| AU1168099A (en) | 1999-06-15 |
| BR9814220A (pt) | 2001-12-26 |
| SK7342000A3 (en) | 2000-12-11 |
| EA200000552A1 (ru) | 2000-10-30 |
| GB9724544D0 (en) | 1998-01-21 |
| CN1279608A (zh) | 2001-01-10 |
| NO20002590D0 (no) | 2000-05-19 |
| DZ2658A1 (fr) | 2003-03-22 |
| TR200001423T2 (tr) | 2000-10-23 |
| AP2000001821A0 (en) | 2000-06-30 |
| HUP0100580A3 (en) | 2002-05-28 |
| PL340555A1 (en) | 2001-02-12 |
| BG104527A (en) | 2001-04-30 |
| OA11385A (en) | 2004-01-27 |
| KR20010032320A (ko) | 2001-04-16 |
| HUP0100580A2 (hu) | 2002-04-29 |
| JP2001523718A (ja) | 2001-11-27 |
| MA24704A1 (fr) | 1999-07-01 |
| WO1999026625A1 (en) | 1999-06-03 |
| AR015485A1 (es) | 2001-05-02 |
| ZA9810637B (en) | 2000-05-22 |
| EP1033986A1 (en) | 2000-09-13 |
| NO20002590L (no) | 2000-07-19 |
| PE20000381A1 (es) | 2000-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2178430T3 (es) | Utilizacion de composiciones farmaceuticas gelificables en parodontologia. | |
| AR017512A1 (es) | Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas | |
| PT1033981E (pt) | Formulacoes e metodos para reduzir a toxicidade de agentes antineoplasicos | |
| AR037490A1 (es) | Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos | |
| ES2190075T3 (es) | Formulaciones farmaceuticas solidas que contienen una mezcla fisica de sulfoalquil-eter-ciclodextrina y un agente terapeutico. | |
| ES2110377T1 (es) | Formulacion galenica de fenofibrato y aplicacion de la misma. | |
| KR950031069A (ko) | 골손실의 억제 및 혈청 콜레스테롤의 강하 방법 | |
| ATE554750T1 (de) | Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen | |
| AU2001283563A1 (en) | Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent | |
| CO5271759A1 (es) | Formulacion en solucion que contiene una mezcla de disolventes | |
| ATE65023T1 (de) | Pharmazeutische mittel. | |
| HUP0201877A2 (hu) | Hal zselatint tartalmazó, gyorsan diszpergálódó dózis formák | |
| ES2144192T3 (es) | Nuevos derivados de 1-fenil-2-dimetil-amino-metil-ciclohexan-1-ol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| BR0215184A (pt) | composições farmacêuticas de derivados de taxano oralmente ativos tendo biodisponibilidade aumentada | |
| ES2157975T3 (es) | Soluciones farmaceuticas con solubilidad mejorada. | |
| ES2126766T3 (es) | 7-azaindol-3-ilcarboxiamidas de tropilo como agente antitusivo. | |
| BR9714310A (pt) | Composição farmacêutica | |
| BR0009770A (pt) | Derivados de bisindóis indigóides capazes de penetrarem na membrana de células, formulação farmacêutica e utilização da mesma | |
| AR013710A1 (es) | Formulaciones orales de ciclosporina | |
| CO4970832A1 (es) | Nuevas formulaciones y procesos para su fabricacion | |
| AR011919A1 (es) | FORMULACIoN EN COMPRIMIDOS O CÁPSULAS PARA TRAGAR DE PARACETAMOL (N-ACETIL-P-AMINOFENOL) Y PROCEDIMIENTO PARA PREPARARLA | |
| HUP9701111A2 (hu) | Töltőanyag lágy zselatin kapszula gyógyszeradagolási formához | |
| PT1073467E (pt) | Formulacoes de co-solvente que compreendem um composo de vitamina d. | |
| IT1263840B (it) | Formulazioni orali di ubidecarenone in forma di capsule | |
| WO2003018064A3 (en) | Lipophilic drug compositions |